Print

Fidelis Diagnostics Partners With Exalenz Bioscience to Add H. pylori Breath Testing Solutions to Its Portfolio of Services  
8/7/2012 10:21:27 AM

LOS ANGELES--(BUSINESS WIRE)--Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, today announced it has entered into a strategic partnership with Exalenz Bioscience, Inc., a medical device company specializing in the diagnosis and monitoring of gastroenterological and liver related diseases. Fidelis Diagnostics will now offer Exalenz’ advanced Helicobacter pylori (H. pylori) Breath Testing System, the BreathID® System, to its expanding base of 2,000 physicians.
//-->